Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human in Vivo Regional Intestinal Permeability: Quantitation Using Site-Specific Drug Absorption Data
Erik Sjögren, David Dahlgren, Carl Roos, et al.
Molecular Pharmaceutics (2015) Vol. 12, Iss. 6, pp. 2026-2039
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches
David Dahlgren, Hans Lennernäs
Pharmaceutics (2019) Vol. 11, Iss. 8, pp. 411-411
Open Access | Times Cited: 203
Permeability Benchmarking: Guidelines for Comparing in Silico, in Vitro, and in Vivo Measurements
Christian Jorgensen, Raleigh M. Linville, Ian Galea, et al.
Journal of Chemical Information and Modeling (2025)
Open Access | Times Cited: 1
In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models
Erik Sjögren, Helena Thörn, Christer Tannergren
Molecular Pharmaceutics (2016) Vol. 13, Iss. 6, pp. 1763-1778
Closed Access | Times Cited: 80
Regional Intestinal Permeability of Three Model Drugs in Human
David Dahlgren, Carl Roos, Anders Lundqvist, et al.
Molecular Pharmaceutics (2016) Vol. 13, Iss. 9, pp. 3013-3021
Closed Access | Times Cited: 66
Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review
Joseph P. O’Shea, Patrick Augustijns, Martin Brandl, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 170, pp. 106098-106098
Open Access | Times Cited: 51
Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report
Xavier Pépin, Neil Parrott, Jennifer B. Dressman, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 2, pp. 555-566
Closed Access | Times Cited: 50
In Vivo Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations
Carl Roos, David Dahlgren, Staffan Berg, et al.
Molecular Pharmaceutics (2017) Vol. 14, Iss. 12, pp. 4233-4242
Closed Access | Times Cited: 52
Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion
Isabel Lozoya-Agulló, Moran Zur, Avital Beig, et al.
International Journal of Pharmaceutics (2016) Vol. 515, Iss. 1-2, pp. 201-208
Closed Access | Times Cited: 50
Regional Intestinal Permeability in Rats: A Comparison of Methods
Carl Roos, David Dahlgren, Erik Sjögren, et al.
Molecular Pharmaceutics (2017) Vol. 14, Iss. 12, pp. 4252-4261
Closed Access | Times Cited: 47
The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs
David Dahlgren, Christian Roos, Pernilla Johansson, et al.
International Journal of Pharmaceutics (2018) Vol. 547, Iss. 1-2, pp. 158-168
Closed Access | Times Cited: 45
Evaluating the Utility of Canine Mdr1 Knockout Madin-Darby Canine Kidney I Cells in Permeability Screening and Efflux Substrate Determination
Eugene C. Chen, Fabio Broccatelli, Emile G. Plise, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 11, pp. 5103-5113
Closed Access | Times Cited: 38
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans
Christer Tannergren, Harshad Jadhav, Emma Eckernäs, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 186, pp. 144-159
Open Access | Times Cited: 11
Challenges in Permeability Assessment for Oral Drug Product Development
Mirko Koziolek, Patrick Augustijns, Constantin Berger, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2397-2397
Open Access | Times Cited: 11
A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats
Janis Niessen, Nathalie Arendt, Markus Sjöblom, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025), pp. 114719-114719
Closed Access
Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms
David Dahlgren, Carl Roos, Pernilla Johansson, et al.
Molecular Pharmaceutics (2016) Vol. 13, Iss. 9, pp. 3022-3033
Closed Access | Times Cited: 34
Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker 51Cr-EDTA
David Dahlgren, Carl Roos, Anders Lundqvist, et al.
Molecular Pharmaceutics (2017) Vol. 14, Iss. 12, pp. 4243-4251
Closed Access | Times Cited: 34
Lost in modelling and simulation?
Kiyohiko Sugano
ADMET & DMPK (2021) Vol. 9, Iss. 2, pp. 75-109
Open Access | Times Cited: 25
Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport
David Dahlgren, Christian Roos, Anders Lundqvist, et al.
International Journal of Pharmaceutics (2018) Vol. 549, Iss. 1-2, pp. 239-248
Closed Access | Times Cited: 31
Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model
David Dahlgren, Christian Roos, Karsten Peters, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 31-37
Closed Access | Times Cited: 26
Six years of progress in the oral biopharmaceutics area – A summary from the IMI OrBiTo project
Bertil Abrahamsson, Mark McAllister, Patrick Augustijns, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 152, pp. 236-247
Open Access | Times Cited: 25
In Vitro Biopredictive Methods: A Workshop Summary Report
Xavier Pépin, Jennifer B. Dressman, Neil Parrott, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 2, pp. 567-583
Open Access | Times Cited: 24
Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats
David Dahlgren, Tobias Olander, Markus Sjöblom, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 6, pp. 1667-1675
Open Access | Times Cited: 23
Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin
Andrés Olivares‐Morales, Avijit Ghosh, Leon Aarons, et al.
The AAPS Journal (2016) Vol. 18, Iss. 6, pp. 1532-1549
Open Access | Times Cited: 26
An in vitro - in silico approach for the formulation and characterization of ranitidine gastroretentive delivery systems
Sandra Cvijić, Svetlana Ibrić, Jelena Parojčić, et al.
Journal of Drug Delivery Science and Technology (2018) Vol. 45, pp. 1-10
Closed Access | Times Cited: 24
Comparison of segmental-dependent permeability in human and in situ perfusion model in rat
Alejandro Ruiz-Picazo, Isabel Lozoya-Agulló, Miguel Ortiz-Azcarate, et al.
European Journal of Pharmaceutical Sciences (2017) Vol. 107, pp. 191-196
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top